Replies to post #138286 on Biotech Values

[DewDiligence]

Since I've dropped by to mention when I've sold out of SNMX in the past, I figured I should also mention that I have re-accumulated an overweight position in the name. Now has <$50m enterprise value.

Is your reentry strictly a valuation call?